SCHEMBL2532810

SCHEMBL2532810

CC(=O)/C(C)=C\c1ccccc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.75
RECQL P46063 1/20 0.57
ALDH1A1 P00352 2/20 0.56
TSHR P16473 1/20 0.56
HTT P42858 1/20 0.55
RAB9A P51151 4/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
NPC1 O15118 2/20 0.51
DHODH Q02127 1/20 0.51
TRPM8 Q7Z2W7 1/20 0.51
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
FBP1 P09467 1/20 0.50
GLA P06280 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
PKM P14618 1/20 0.49
MAPK1 P28482 1/20 0.49
AKR1C1 Q04828 1/20 0.48
F2 P00734 1/20 0.47
GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL805622 1.00 AKR1C3 (0.75) AKR1C3RECQLALDH1A1TSHRHTT
SCHEMBL874087 1.00 AKR1C3 (0.75) AKR1C3RECQLALDH1A1TSHRHTT
SCHEMBL581982 0.86 AKR1C3 (1.00) AKR1C3RECQLALDH1A1TSHRHTT
SCHEMBL16568719 0.86 AKR1C3 (1.00) AKR1C3RECQLALDH1A1TSHRHTT
SCHEMBL37034 0.86 AKR1C3 (1.00) AKR1C3RECQLALDH1A1TSHRHTT
SCHEMBL759656 0.86 AKR1C3 (0.75) AKR1C3RECQLALDH1A1TSHRHTT
SCHEMBL759655 0.86 AKR1C3 (0.75) AKR1C3RECQLALDH1A1TSHRHTT
SCHEMBL41906 0.86 AKR1C3 (1.00) AKR1C3RECQLALDH1A1TSHRHTT
SCHEMBL23458002 0.85 AKR1C3 (0.73) AKR1C3RECQLALDH1A1TSHRHTT
SCHEMBL6433811 0.85 AKR1C3 (0.73) AKR1C3RECQLALDH1A1TSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3416729-B1 PRO-FRAGRANCE COMPOSITION AQDOT LTD (GB) 2023-09-20 EP disclosed
CN-110891615-B System and method for selecting and releasing fragrance 阿甘香气及精细化学有限公司 2022-08-05 CN disclosed
CN-108601958-B Pro-fragrance compositions 爱客多有限公司 2022-06-17 CN disclosed
US-10695277-B2 Pro-fragrance composition AQDOT LIMITED (GB) 2020-06-30 US disclosed
US-20190046426-A1 PRO-FRAGRANCE COMPOSITION AQDOT LIMITED (GB) 2019-02-14 US disclosed
EP-3416729-A1 PRO-FRAGRANCE COMPOSITION Aqdot Limited (GB) 2018-12-26 EP disclosed
WO-2017141030-A1 PRO-FRAGRANCE COMPOSITION AQDOT LIMITED (GB) 2017-08-24 WO disclosed
CN-106999973-A System and method for discharging edible material 阿甘芳香和精细化工有限公司 2017-08-01 CN disclosed
CN-106999972-A System and method for discharging fragrance 阿甘芳香和精细化工有限公司 2017-08-01 CN disclosed
US-8168642-B2 Dihydropyrimidine compounds and their uses in preparation of medicaments for treating and preventing antiviral diseases BEIJING MOLECULE SCIENCE AND TECHNOLOGY CO., LTD. (CN) 2012-05-01 US disclosed
US-20110257430-A1 NOVEL COCRYSTALLIZATION APTUIT (KANSAS CITY), LLC (US) 2011-10-20 US disclosed
US-20100248390-A1 COMPOSITIONS AND METHODS FOR IDENTIFYING LIGANDS OF ODORANT RECEPTORS DUKE UNIVERSITY (US) 2010-09-30 US disclosed
US-20100087448-A1 Dihydropyrimidine Compounds and Their Uses in Preparation of Medicaments for Treating and Preventing Antiviral Diseases BEIJING MOLECULE SCIENCE AND TECHNOLOGY CO., LTD. (CN) 2010-04-08 US disclosed
US-4582634-A ORGANOLEPTIC INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1986-04-15 US disclosed
US-4507225-A Process for augmenting or enhancing the aroma of perfume compositions, colognes and perfumed articles with 1-phenylpenten-4-one-1 and methyl homologues thereof INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1985-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190046426-A1 PRO-FRAGRANCE COMPOSITION COPS5, COPS8, CBR3 AKR1C3 3291/4885RECQL 4505/4885ALDH1A1 1526/4885
US-20100087448-A1 Dihydropyrimidine Compounds and Their Uses in Preparation of Medicaments for Treating and Preventing Antiviral Diseases DPYD, HPRT1, DHX15 AKR1C3 1600/4885RECQL 121/4885ALDH1A1 424/4885
US-10695277-B2 Pro-fragrance composition COPS5, COPS8, CBR3 AKR1C3 3291/4885RECQL 4505/4885ALDH1A1 1526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.